Pfam Domains GO Terms
| PHD |
| ubiquitin |
| DUF3590 |
| YDG SRA |
| hemi-methylated DNA-binding |
| nucleosomal histone binding |
| regulation of DNA topoisomerase (ATP-hydrolyzing) activity |
| maintenance of DNA methylation |
| positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity |
| euchromatin |
| positive regulation of isomerase activity |
| regulation of isomerase activity |
| nuclear heterochromatin |
| replication fork |
| heterochromatin |
| methyl-CpG binding |
| histone monoubiquitination |
| proximal promoter sequence-specific DNA binding |
| histone ubiquitination |
| positive regulation of ATPase activity |
| methylated histone binding |
| protein monoubiquitination |
| protein autoubiquitination |
| regulation of ATPase activity |
| nuclear matrix |
| histone binding |
| ubiquitin protein ligase activity |
| nuclear chromatin |
| ubiquitin-protein transferase activity |
| regulation of epithelial cell proliferation |
| histone modification |
| covalent chromatin modification |
| DNA repair |
| ubiquitin-dependent protein catabolic process |
| modification-dependent protein catabolic process |
| modification-dependent macromolecule catabolic process |
| proteolysis involved in cellular protein catabolic process |
| cellular protein catabolic process |
| protein catabolic process |
| protein ubiquitination |
| chromatin organization |
| DNA metabolic process |
| positive regulation of hydrolase activity |
| protein modification by small protein conjugation |
| cellular response to DNA damage stimulus |
| zinc ion binding |
| negative regulation of transcription by RNA polymerase II |
| cellular macromolecule catabolic process |
| protein modification by small protein conjugation or removal |
| macromolecule catabolic process |
| organonitrogen compound catabolic process |
| chromosome organization |
| identical protein binding |
| negative regulation of transcription, DNA-templated |
| positive regulation of transcription by RNA polymerase II |
| negative regulation of nucleic acid-templated transcription |
| negative regulation of RNA biosynthetic process |
| proteolysis |
| regulation of hydrolase activity |
| negative regulation of RNA metabolic process |
| cell cycle |
| negative regulation of cellular macromolecule biosynthetic process |
| positive regulation of catalytic activity |
| negative regulation of nucleobase-containing compound metabolic process |
| negative regulation of macromolecule biosynthetic process |
| negative regulation of cellular biosynthetic process |
| positive regulation of transcription, DNA-templated |
| negative regulation of biosynthetic process |
| positive regulation of cellular protein metabolic process |
| regulation of cell population proliferation |
| positive regulation of nucleic acid-templated transcription |
| positive regulation of RNA biosynthetic process |
| cellular response to stress |
| positive regulation of protein metabolic process |
| negative regulation of gene expression |
| positive regulation of RNA metabolic process |
| organic substance catabolic process |
| positive regulation of molecular function |
| cellular catabolic process |
| positive regulation of nucleobase-containing compound metabolic process |
| positive regulation of macromolecule biosynthetic process |
| positive regulation of cellular biosynthetic process |
| positive regulation of gene expression |
| positive regulation of biosynthetic process |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Gene | Correlation |
|---|---|
| ALG1 | 0.661 |
| THG1L | 0.647 |
| PMM2 | 0.631 |
| DPAGT1 | 0.603 |
| RPTOR | 0.603 |
| UAP1 | 0.599 |
| HARS | 0.582 |
| RTCB | 0.581 |
| RNMT | 0.577 |
| GFPT1 | 0.576 |
| TRIAP1 | 0.565 |
| GTF3C6 | 0.562 |
| YARS | 0.56 |
| RPP21 | 0.56 |
| ATXN10 | 0.559 |
| GMPPB | 0.558 |
| VEZT | 0.557 |
| FH | 0.554 |
| ALG13 | 0.553 |
| DOHH | 0.552 |
| SRP14 | 0.547 |
| PPCS | 0.547 |
| ADSL | 0.545 |
| CBFB | 0.545 |
| SLC25A26 | 0.545 |
| LSM10 | 0.545 |
| DHPS | 0.536 |
| GNB1L | 0.536 |
| NAE1 | 0.535 |
| OSGEP | 0.534 |
| PPP2R3C | 0.533 |
| GEMIN6 | 0.531 |
| TEN1 | 0.53 |
| GEMIN8 | 0.527 |
| TTI1 | 0.525 |
| WDR24 | 0.519 |
| PELO | 0.517 |
| PPP4C | 0.515 |
| TRMT5 | 0.515 |
| ELAC2 | 0.51 |
| LSM11 | 0.509 |
| NBN | 0.508 |
| CCDC101 | 0.505 |
| UTP23 | 0.498 |
| MED16 | 0.497 |
| SUPV3L1 | 0.497 |
| BAP1 | 0.496 |
| TMEM41B | 0.493 |
| RFK | 0.492 |
| PPP6C | 0.49 |
| UXT | 0.49 |
| RPE | 0.49 |
| RPIA | 0.489 |
| ZRSR2 | 0.488 |
| CTC1 | 0.486 |
| GTF3C3 | 0.485 |
| DDX20 | 0.484 |
| ENY2 | 0.483 |
| CHCHD4 | 0.483 |
| EIF3F | 0.483 |
| ROMO1 | 0.48 |
| CCT7 | 0.48 |
| ALG5 | 0.478 |
| MRPS33 | 0.476 |
| ATP5J | 0.474 |
| DOLK | 0.473 |
| EXOC4 | 0.473 |
| TGS1 | 0.473 |
| TAZ | 0.472 |
| ENO1 | 0.47 |
| WDR59 | 0.47 |
| GEMIN7 | 0.47 |
| MRPS14 | 0.469 |
| THOC6 | 0.468 |
| MLLT1 | 0.468 |
| SLC25A19 | 0.468 |
| HAUS8 | 0.467 |
| EIF4E | 0.467 |
| MED23 | 0.466 |
| GTF3C4 | 0.465 |
| MTOR | 0.464 |
| GTF3C2 | 0.464 |
| ATP5O | 0.464 |
| UBA3 | 0.461 |
| POLR3H | 0.459 |
| TRNT1 | 0.459 |
| AASDHPPT | 0.459 |
| TBCB | 0.457 |
| DR1 | 0.457 |
| RBMX2 | 0.456 |
| SNAPC5 | 0.456 |
| TELO2 | 0.456 |
| MED4 | 0.455 |
| MRPS34 | 0.454 |
| TUFM | 0.451 |
| EPRS | 0.45 |
| TPRKB | 0.449 |
| SSB | 0.448 |
| TAMM41 | 0.448 |
| CBX3 | 0.448 |
| DDX39A | 0.448 |
| TRMT10A | 0.447 |
| TTI2 | 0.446 |
| TSEN54 | 0.443 |
| HSD17B10 | 0.442 |
| SARS2 | 0.442 |
| PPA2 | 0.441 |
| UBE2G2 | 0.441 |
| TBCA | 0.441 |
| CSNK2B | 0.439 |
| PGGT1B | 0.438 |
| UQCRC2 | 0.437 |
| HSPD1 | 0.436 |
| ALG2 | 0.436 |
| TXNL4B | 0.435 |
| FNTA | 0.433 |
| KIAA0391 | 0.433 |
| DHRSX | 0.432 |
| GEMIN5 | 0.431 |
| MAPK14 | 0.43 |
| NARS | 0.429 |
| C15orf41 | 0.429 |
| ATP5H | 0.428 |
| DHX29 | 0.428 |
| VMP1 | 0.427 |
| GPN2 | 0.426 |
| TAF1A | 0.425 |
| RFT1 | 0.424 |
| LAMTOR5 | 0.424 |
| TTC4 | 0.424 |
| DPF2 | 0.424 |
| TPK1 | 0.424 |
| KCTD5 | 0.42 |
| DDX55 | 0.419 |
| YARS2 | 0.419 |
| WDR1 | 0.419 |
| CEP57 | 0.419 |
| AARS | 0.418 |
| CRLS1 | 0.418 |
| CTDNEP1 | 0.417 |
| PIK3R4 | 0.417 |
| C17orf89 | 0.417 |
| MAML1 | 0.416 |
| ATP5B | 0.416 |
| ZCRB1 | 0.415 |
| EEF1E1 | 0.415 |
| TIMM13 | 0.415 |
| UBE2M | 0.414 |
| NSMCE1 | 0.413 |
| GTF2A2 | 0.412 |
| WDR82 | 0.412 |
| TSEN34 | 0.411 |
| RAD1 | 0.41 |
| ORC5 | 0.41 |
| ATIC | 0.41 |
| VRK1 | 0.409 |
| MRPS18A | 0.409 |
| ALG6 | 0.409 |
| EED | 0.408 |
| NDUFB1 | 0.408 |
| PSMG4 | 0.407 |
| HCCS | 0.406 |
| TXNRD1 | 0.405 |
| XRCC2 | 0.404 |
| OIP5 | 0.404 |
| RAD50 | 0.404 |
| CRCP | 0.404 |
| BCS1L | 0.402 |
| DARS2 | 0.401 |
| SRD5A3 | 0.401 |
| GFM1 | 0.401 |
| LAMTOR4 | 0.401 |
| Tissue | Fraction Of Cell Lines Where Essential |
|---|
Expression Distribution